Cargando…

ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity

Detalles Bibliográficos
Autor principal:	Gan, Boyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033814/ https://www.ncbi.nlm.nih.gov/pubmed/35459217 http://dx.doi.org/10.1038/s41392-022-01004-z

Ejemplares similares

PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunity
por: Lei, Guang, et al.
Publicado: (2022)

Uncovering the IL‐1β‐PCAF‐NNT axis: A new player in ferroptosis and tumor immune evasion
por: Li, Qidong, et al.
Publicado: (2023)

An anti-tumor coup: TIM3 ablation activates the immune arsenal
por: Görgülü, Kıvanç, et al.
Publicado: (2021)

Highlight: The Evolutionary Arsenal of Aphids
por: McGrath, Casey
Publicado: (2018)

ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
por: Yang, Yufei, et al.
Publicado: (2022)

Dissecting an adiposity locus with an arsenal of genomics
por: Lorenz, Kim, et al.
Publicado: (2018)

BET family protein degraders poised to join the senolytic arsenal
por: Guo, Zufeng, et al.
Publicado: (2020)

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
por: Yang, Chang, et al.
Publicado: (2021)

ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression
por: Grube, Julia, et al.
Publicado: (2022)

Peroxisome: the new player in ferroptosis
por: Tang, Daolin, et al.
Publicado: (2020)

Integrative analysis links ferroptosis to necrotizing enterocolitis and reveals the role of ACSL4 in immune disorders
por: Dang, Dan, et al.
Publicado: (2022)

ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke
por: He, Sixiao, et al.
Publicado: (2022)

ACSL4 is essential for radiation-induced intestinal injury by initiating ferroptosis
por: Ji, Qian, et al.
Publicado: (2022)

ACSL4 suppresses glioma cells proliferation via activating ferroptosis
por: Cheng, Jing, et al.
Publicado: (2020)

Relationship Between ACSL4-Mediated Ferroptosis and Chronic Obstructive Pulmonary Disease
por: Wang, Yingxi, et al.
Publicado: (2023)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
por: Du, Songtao, et al.
Publicado: (2023)

Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion
por: Tuo, Qing-zhang, et al.
Publicado: (2022)

Vitamin D Attenuates Ulcerative Colitis by Inhibiting ACSL4-Mediated Ferroptosis
por: Gao, Shuo, et al.
Publicado: (2023)

Identification of immune‐activating metabolite for enhancing T cell therapy of cancer
por: Cong, Boyi, et al.
Publicado: (2021)

ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury
por: Wang, Yue, et al.
Publicado: (2022)

Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
por: Freeman, Andrew J., et al.
Publicado: (2020)

Ferroptosis: the Good, the Bad and the Ugly
por: Aldrovandi, Maceler, et al.
Publicado: (2020)

Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling
por: Tian, Xiangyang, et al.
Publicado: (2021)

IL-18: throwing off the shackles to boost anti-tumor immunity
por: Dixon, Karen O., et al.
Publicado: (2020)

High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma
por: Zhang, Yixiang, et al.
Publicado: (2021)

Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection
por: Xia, Huawei, et al.
Publicado: (2021)

ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model
por: Cao, Dianyu, et al.
Publicado: (2023)

The thioredoxin system: Balancing redox responses in immune cells and tumors
por: Muri, Jonathan, et al.
Publicado: (2022)

Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma
por: Guo, Na
Publicado: (2022)

Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis
por: Fan, Zhenyu, et al.
Publicado: (2021)

ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries
por: Jia, Bowen, et al.
Publicado: (2023)

Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis
por: Merkel, Melanie, et al.
Publicado: (2023)

YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones
por: Li, Lei, et al.
Publicado: (2023)

Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism
por: Ding, Kaiyue, et al.
Publicado: (2023)

A new perspective on immune evasion: escaping immune surveillance by inactivating tumor suppressors
por: Mergener, Svenja, et al.
Publicado: (2022)

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
por: Zeng, Kaixuan, et al.
Publicado: (2023)

CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer
por: Chen, Congcong, et al.
Publicado: (2023)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Immune receptor mimicking hormone receptors: a new guarding strategy
por: Liu, Xueru, et al.
Publicado: (2023)

RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis
por: Wang, Mu-En, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_knst8v00pc5ts0qa2660qv6jrm